AJP - Heart BIOPAC complete lab solutions
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 288: H2332-H2341, 2005. First published January 14, 2005; doi:10.1152/ajpheart.00473.2004
0363-6135/05 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/5/H2332    most recent
00473.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (26)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zheng, H.
Right arrow Articles by Patel, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zheng, H.
Right arrow Articles by Patel, K. P.

Exercise training improves endogenous nitric oxide mechanisms within the paraventricular nucleus in rats with heart failure

Hong Zheng, Yi-Fan Li, Kurt G. Cornish, Irving H. Zucker, and Kaushik P. Patel

Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, Nebraska

Submitted 20 May 2004 ; accepted in final form 29 December 2004


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Previously, we have demonstrated that an altered endogenous nitric oxide (NO) mechanism within the paraventricular nucleus (PVN) contributes to increased renal sympathetic nerve activity (RSNA) in heart failure (HF) rats. The goal of this study was to examine the effect of exercise training (ExT) in improving the endogenous NO mechanism within the PVN involved in the regulation of RSNA in rats with HF. ExT significantly restored the decreased number of neuronal NO synthase (nNOS)-positive neurons in the PVN (129 ± 17 vs. 99 ± 6). nNOS mRNA expression and protein levels in the PVN were also significantly increased in HF-ExT rats compared with HF-sedentary rats. To examine the functional role of NO within the PVN, an inhibitor of NOS, NG-monomethyl-L-arginine, was microinjected into the PVN. Dose-dependent increases in RSNA, arterial blood pressure (BP), and heart rate (HR) were produced in all rats. There was a blunted increase in these parameters in HF rats compared with the sham-operated rats. ExT significantly augmented RSNA responses in rats with HF (33% vs. 20% at the highest dose), thus normalizing the responses. The NO donor sodium nitroprusside, microinjected into the PVN, produced dose-dependent decreases in RSNA, BP, and HR in both sham and HF rats. ExT significantly improved the blunted decrease in RSNA in HF rats (36% vs. 17% at the highest dose). In conclusion, our data indicate that ExT improves the altered NO mechanism within the PVN and restores NO-mediated changes in RSNA in rats with HF.

neuronal nitric oxide synthase; neuromodulator; neurohumoral drive; renal sympathetic nerve activity


HEART FAILURE (HF) is typically characterized by impaired cardiovascular reflexes and an increased neurohumoral drive (42, 44). This sympathoexcitatory state increases the progression and risk of mortality during HF (32). The mechanisms underlying these abnormalities are poorly understood. This issue is complex and has been of interest to both clinicians and basic scientists. In recent years, several studies have suggested that altered central mechanisms may be responsible for the elevated neurohumoral drive in HF (27, 31, 44).

It is well established that the paraventricular nucleus (PVN) is an important central site for integration of autonomic and neuroendocrine responses (54, 55). Neuroanatomic and electrophysiological data have indicated that the PVN is reciprocally connected to other areas of the central nervous system that are involved in cardiovascular function (54). With the use of retrograde tracing techniques, it has been shown that the PVN is a major source of forebrain input to the sympathetic nervous system (51). Functional studies have also revealed that the PVN is involved in cardiovascular regulation (25). In recent years, we have begun to examine the involvement of central cardiovascular processing mechanisms in the elevated neurohumoral drive in HF (57, 59). The PVN, known to dictate sympathetic outflow, demonstrates an increased neuronal activity in HF (47). The alterations in the neuronal activity of the PVN may be responsible in part for alterations in overall sympathetic nerve activity in HF.

The PVN is a nucleus on which a number of different neurotransmitters converge to influence its neuronal activity (20, 54, 55). Some studies have shown that administration of a nitric oxide (NO) donor into the PVN elicits a decrease in renal sympathetic nerve activity (RSNA) and administration of an inhibitor of NO synthase (NOS) within the PVN increases RSNA (20). This indicates that endogenous NO within the PVN is inhibitory to sympathetic outflow.

The HF condition is known to produce attenuated vasodilation in response to agonists known to operate via a NO mechanism (15). The levels of endogenous endothelial NOS (eNOS) protein and mRNA in peripheral tissue are reduced in the HF state (52). We have recently shown that the message for neuronal NOS (nNOS) in the hypothalamus and NOS-positive neurons (NADPH-positive neurons) are decreased in the PVN of rats with HF compared with sham-operated rats (59). We also found that NO-mediated inhibition of RSNA within the PVN was blunted in rats with HF (56). This set of observations suggests that an altered NO mechanism may contribute to the increased sympathetic nerve activity in the HF state.

Patients with HF benefit from a consistent exercise regimen (1, 6). It has been shown that long-term regular exercise training (ExT) of patients with HF increases the quality of life as well as survival (5). Both chronic and acute exercise has been shown to have an effect on resting arterial pressure and cardiovascular regulation (3). The mechanisms by which ExT improves the status of HF patients and animals are not known. Although ExT has been shown to enhance endothelial function in the patients and animals with HF (21), there are little data on the role of ExT in the modulation of neurohumoral drive. ExT has been shown to attenuate muscle sympathetic nerve activity in patients with dilated cardiomyopathy (50). In patients with ischemic heart disease, ExT produces a decrease in plasma concentrations of norepinephrine, an index of neurohumoral drive (50). Recently, the data have demonstrated that daily exercise increases the number of NOS-positive neurons within the PVN of hypertensive rats (12). We hypothesize that ExT may alter sympathetic outflow in HF via a NO-dependent pathway.

To determine the effects of ExT on altered NO mechanisms within the PVN in rats with HF, this study was designed to examine whether ExT would normalize 1) nNOS-positive cells and nNOS mRNA and nNOS protein levels within the PVN of HF rats compared with sham-operated control rats and 2) both endogenous and exogenous NO-mediated changes in RSNA in rats with HF compared with sham-operated control rats.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Induction of HF

All the procedures on animals in this study were approved by the University of Nebraska Medical Center Institutional Animal Care and Use Committee. The experiments were conducted according to the American Physiological Society's "Guiding Principles for Research Involving Animals and Human Beings" and the National Institutes of Health Guide for the Care and Use of Laboratory Animals.

Male Sprague-Dawley rats weighing 180–200 g were obtained from Sasco Breeding Laboratories (Omaha, NE) and were randomly assigned to a sham-operated group and a HF group. HF was produced by coronary artery ligation, as previously described (22, 49). Each rat was anesthetized with pentobarbital sodium (50 mg/kg ip). The trachea was intubated, and the rat was placed on a ventilator. A left thoracotomy was performed, and the left coronary artery was ligated. Sham-operated rats underwent thoracotomy and manipulation of the heart, but the coronary artery was not ligated. Analgesics (Nubain-Stadol, 1 ml/kg sc) were administered on each of the first 2 days after the surgery. Each rat was caged individually in an environment with ambient temperature maintained at 22°C and humidity at 30–40%. Laboratory chow (Harlan; Madison, WI) and tap water were available ad libitum.

ExT Protocol

ExT was conducted 4 wk after ligation of the coronary artery or sham surgery in the rats. The rats were exercised according to the protocols used by Musch and Terrell (41). For a 3-wk period, the rats run on a motor-driven treadmill. During this training period, rats were exercised 10 min/day at an initial treadmill speed of 10 m/min up a 0% grade. To ensure that a significant endurance ExT effect was produced, the treadmill grade and speed were gradually increased to 10% and 20–25 m/min, respectively, and the exercise duration was increased to 60 min/day. Sham and HF rats had the same total work load (5 days/wk for a total of 3 wk). In the study, about 10% of rats did not run adequately on the treadmill without electric shock and were thus eliminated from the analysis. The number of rats eliminated was similar between sham and HF groups. Electric shock was seldom used to aid running performance (just in the last minutes of the running, less than twice every 5 min). The sham-operated control rats were handled daily and treated similarly to the ExT rats except for the running. The time after the last exercise session to conduct the acute experiments was 20–24 h.

Skeletal Muscle Oxidative Enzyme Activity

To test the efficacy of ExT, at the time of death, muscle samples were taken from the soleus muscle, frozen at –70°C, and stored until processed. Citrate synthase activity was measured spectrophotometrically from whole muscle homogenate as previously described (53).

Experimental Series 1: NADPH-Diaphorase Activity as a Marker of nNOS Activity

After ExT, the rats from all four groups (sham-sedentary, n = 9; sham-ExT, n = 7; HF-sedentary, n = 8; and HF-ExT, n = 8) were anesthetized with pentobarbital (65 mg/kg) and perfused through the left ventricle of the heart with 100–150 ml of heparinized saline followed by 200–250 ml of 4% paraformaldehyde in 0.1 M sodium phosphate buffer. The brain was removed and postfixed at 4°C for 4 h in 4% paraformaldehyde solution and then placed in 20% sucrose for 24 h. The brain was blocked in the coronal plane, and sections of 30 µm in thickness were cut with a cryostat. Every third section was kept from the anterior commissure (0.4 mm posterior to bregma) posterior to where the optic tracts were observed to be in their most lateral position on the ventral surface of the brain (2.6 mm posterior to bregma). The sections were collected in 0.1 M phosphate containing 0.3% Triton X-100, 0.1 mg/ml nitroblue tetrazolium, and 1.0 mg/ml {beta}-NADPH. The sections in nitroblue tetrazolium solution were then placed in an oven at 37°C for 1 h. After the reaction, the sections were rinsed in phosphate buffer and mounted onto slides.

The presence of NADPH-diaphorase in the PVN, supraoptic nucleus (SON), lateral hypothalamus (LH), and median preoptic area (MnPO) were examined under a microscope. The density of the staining was evaluated by counting the number of cells that were positively stained for NADPH-diaphorase. The number of NADPH-diaphorase-stained cells was counted for each individual nucleus at the same coronal level. Three adjacent sections were considered to represent one coronal level because the numbers of cells counted were within 5% of each other. The number of cells in the middle section was taken to represent the number of cells within a given nucleus.

Experimental Series 2: Semiquantitative RT-PCR Measurement for nNOS mRNA and Western Blot Analysis for nNOS Protein

RT-PCR for measurement of mRNA expression of nNOS. Four groups of rats (sham-sedentary, n = 6; sham-ExT, n = 6; HF-sedentary, n = 6; and HF-ExT, n = 6) were over anesthetized with pentobarbital and killed. The brain was removed, frozen on dry ice, and then stored at –70°C. A thick coronal section (600 µm) was cut through the hypothalamus at the level of the PVN, and the PVN area was punched out with a 15-gauge needle stub using the Palkovits technique (43). The punched tissue was put in 0.5 ml of Tri-Reagent and homogenized. Total RNA and proteins in the homogenate were extracted according to the Tri-Reagent manufacturer's instructions.

Semiquantitative RT-PCR assays were performed to assess relative mRNA levels. RNA was isolated followed by RT for 40 min at 37°C in the presence of 1.5 µM random hexamers and 400 units of Moloney murine leukemia virus reverse transcriptase. Each 1.5 µl aliquot of the RT product was used for nNOS cDNA amplification. The following PCR primers were used: nNOS, 5'-GCGGAGCAGAGCGGCCTTAT-3' (sense); 5'-TTTGGTGGGAGGACCGAGGG-3' (antisense); and {beta}-actin, 5'-GGGAAATCGTGCGTGACATT-3' (sense); 5'-CGGATGTCAACGTCACACTT-3' (antisense). The PCR mixture contained 0.7 µM primers, dNTP, and BSA and 1 unit of Taq DNA polymerase. {beta}-Actin was coamplified with each receptor cDNA as an internal control. After 10 min of denaturing at 94°C, the amplification was performed at 94°C for 1 min, at 56°C for 1 min, and at 72°C for 1 min for 34 cycles with the final extension at 72°C for 10 min. PCR products (7 µl) were fractionated in a 1% agarose gel and visualized by ethidium bromide staining and ultraviolet transillumination. The visualized DNA bands were captured by a Kodak digital camera and loaded into the computer. The intensities of the bands were analyzed with Kodak 1D image analysis software.

Western blot analysis of nNOS protein. The protein extraction was used for Western blot analysis of nNOS in samples obtained above. The protein concentration was measured using a protein assay kit (BCA kit, Pierce). The protein sample was mixed with an equal volume of 2x 4% SDS sample buffer. The sample was boiled for 5 min and then loaded onto the 7.5% SDS-PAGE gel for electrophoresis at 40 mA/each gel for 50 min. The fractionated proteins on the gel were electrophoretically transferred onto the polyvinylidene diflouoride membrane at 300 mA for 90 min. The membrane was incubated with 5% milk-Tris-buffered saline-Tween 20 solution for 30 min at room temperature. The membrane was incubated with primary antibody (rabbit anti-rat nNOS polyclonal antibody, Santa Cruz Biotechnology, 1:1,000) at 4°C overnight. After being washed three times, the membrane was incubated with secondary antibody (goat anti-rabbit IgG, peroxidase conjugated, Pierce, 1:5,000) for 30 min at room temperature. After being washed three times, the membrane was treated with enhanced chemiluminescence reagent for 5 min and detected by exposing a film. The visualized bands on the developed film were captured with a Kodak digital camera and loaded into the computer. The intensities of the bands were analyzed with Kodak 1D image analysis software.

Experimental Series 3: Recording of RSNA, Blood Pressure, Heart Rate, Left Ventricular End-Diastolic Pressure, and dP/dt

Four groups of rats were used (sham-sedentary, sham-ExT, HF-sedentary, and HF-ExT). On the day of the experiment, the rat was anesthetized with urethane (0.75 g/kg ip) and {alpha}-chloralose (70 mg/kg ip). Additional anesthesia was administered as needed (0.25 g/kg urethane and 20 mg/kg ip {alpha}-chloralose). This supplemental anesthesia was not different between the groups. The animal was ventilated to breath room air. The body temperature was monitored during the experiment period and kept 37°C using a heating pad. The left femoral vein was cannulated for drug administration if necessary, and the left femoral artery was cannulated and connected to MacLab via a pressure transducer for recording of arterial blood pressure (BP) and heart rate (HR). During the experiments, we infused isotonic saline to maintain hydration (2–3 ml/h) and stabilize arterial BP.

The left kidney was exposed through a left retroperitoneal flank incision. A branch of the renal nerve was isolated. The nerve was placed on a bipolar steel electrode. The nerve-electrode junction was fixed and insulated electrically from the surrounding tissues with a mixture of Wacker SilGel 604 and 601. The electrical signal from the electrode was amplified 10,000 times with a Grass amplifier with high- and low-frequency cutoffs of 1,000 and 100 Hz. The output from the Grass amplifier was directed to the MacLab, and the raw discharge and integrated voltage of the renal nerve discharge were recorded and stored for later analysis. Efferent RSNA at the beginning of the experiment was defined as basal nerve discharge. The nerve discharge recorded at the end of the experiment after the rat was injected with hexamethonium (intravenous) or dead was deemed background noise. The value of nerve discharge was calculated by subtracting the background noise from the actual recording value. The response of renal nerve discharge to the administration of drugs into the PVN during the experiment was subsequently expressed as the percent change from the basal value.

At the end of each acute experiment, the left ventricle was cannulated via the carotid artery and connected to MacLab via a pressure transducer for recording of left ventricular end-diastolic pressure (LVEDP) and dP/dt.

Microinjection Into the PVN

The rat was placed in a stereotaxic apparatus. A burr hole was placed in the skull. The coordinates for the right PVN was determined from the Paxinos and Watson rat atlas (48), which is 1.5 mm posterior, 0.5 mm lateral to the bregma, and 8.0 mm ventral to the dura. A cannula connected to a microsyringe (0.5 µl) was advanced into the right side PVN with a manipulator. The volumes of injection were 50, 100, and 200 nl. At the end of the experiments, monastral blue dye was injected into the brain for histological verification of the injection. After the rat was killed, the brain was removed and fixed in 4% formaldehyde for at least 24 h. The brain was then frozen, and serial transverse sections (30 µm) were cut using a cryostat at –18°C. The sections were thaw mounted on microscope slides and stained with 1% aqueous neutral red staining procedures. The presence of the blue dye within the PVN was verified under a microscope with x40 magnification.

Experiment protocol 1. RSNA, BP, and HR were measured in sham-sedentary (n = 10), HF-sedentary (n = 10), sham-ExT (n = 8), and HF-ExT (n = 10) rats. An inhibitor of NOS, NG-monomethyl-L-arginine (L-NMMA), was injected into the PVN in three doses (50, 100, and 200 pmol in 50, 100, and 200 nl, respectively). The doses were given consecutively at intervals of 20 min. Maximum changes in RSNA, BP, and HR were determined after each dose.

Experiment protocol 2. RSNA, BP, and HR were measured in sham-sedentary (n = 10), HF-sedentary (n = 10), sham-ExT (n = 8), and HF-ExT (n = 10) rats. A NO donor, sodium nitroprusside (SNP), was injected into the PVN in three doses (5, 10, and 20 nmol in 50, 100, and 200 nl, respectively). The doses were given consecutively at intervals of 20 min. Maximum changes in RSNA, BP, and HR were determined after each dose.

Cardiac Histology

At the end of each experiment, the heart was removed, weighed, and fixed in 4% formaldehyde. The infarct size was determined as previously described (46, 47). Briefly, the hearts were sectioned into four major segments located from the atrium to the apex: segments A–D. Segment A (the atria and the connecting inflow and outflow tracts) and segment D (mainly the apex) were not analyzed for histological damage. Segments B and C (representing the bulk of the left ventricle) were subjected to graded dehydration with ethanol, embedded in paraffin, cut into sequential 10-µm sections, and stained with hematoxylin-eosin. Every 10th section was projected onto a screen, and the outline of the tissue was diagramed after microscopic examination of the infarcted areas of the ventricle to identify the edges of the infarct area. The infarct size was expressed as a fraction of the total cross-sectional epicardial circumferences of the left ventricle.

Data Analysis

Responses of RSNA to the drugs were reported as the percent change from the basal value. Responses of mean BP and HR were expressed as the difference between the basal value and the value after each dose of a drug. Data were subjected to two-way ANOVA followed by Newman Keuls test (for multiple comparisons) or Student’s t-test. P < 0.05 was considered to indicate statistical significance.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Baseline Data (Group Characteristics)

Table 1 summarizes the salient characteristics of sham and HF rats utilized in the present study. Heart weight, body weight, and lung wet weight were significantly higher in HF-sedentary rats compared with sham-sedentary rats (P < 0.05). This indicates that retention of water occurs in HF rats. ExT significantly lowered the body weight and lung wet weight in the HF group.


View this table:
[in this window]
[in a new window]
 
Table 1. Characteristics of sham-operated and HF rats in the microinjection experiments

 
The HF group displayed an average myocardial infarct size over 30% of the left ventricle. Sham rats had no observable damage to the myocardium. LVEDP was significantly elevated in HF rats compared with sham rats (P < 0.05). +dP/dtmax was significantly decreased in HF rats, indicating a decreased contractility that was manifest as an increase in LVEDP. –dP/dtmax had a similar trend in rats with HF. These data suggest that the rats in the HF group had decreased cardiac contractile and diastolic function. ExT did not significantly change LVEDP in either sham or HF groups. In the HF group, the LVEDP level tended to be lower in the ExT group versus the sedentary group. Furthermore, ExT had no effect on ±dP/dtmax in either the sham or HF groups. However, there was no significant difference in ±dP/dtmax between the HF-ExT group and sham-sedentary group.

Table 1 contains the baseline hemodynamic values and RSNA in the four groups of rats. There were no statistically significant differences in basal mean BP and HR among the four groups. ExT tended to lower HR in both the sham and HF groups. Basal RSNA in rats with HF tended to be higher than that in sham rats. ExT tended to lower the basal level of RSNA in HF rats.

The concentration of citrate synthase in the soleus muscle was significantly increased in the ExT groups (P < 0.05), consistent with previous reports (30). The level of citrate synthase activity in the soleus muscle was comparable in the two exercise groups, indicative of similar levels of ExT.

Experimental Series 1: NADPH-Diaphorase Activity as a Marker of nNOS Activity

As shown in Fig. 1, with the technique of NADPH-diaphorase staining, the PVN is clearly outlined, and cells of medium to large size were observed in the PVN, most of which were concentrated in the ventral and lateral portion of the PVN. The number of NOS-positive cells in the PVN of HF-sedentary rats was significantly less than that found in the other groups (30% less, P < 0.05). In rats with HF, ExT restored the decreased number of nNOS-positive neurons in the PVN. The number of cells stained for diaphorase in the PVN in the sham-sedentary, sham-ExT, and HF-ExT groups was significantly greater than that in HF-sedentary group (Fig. 2). There were no significant changes in the number of NADPH-diaphorase-positive cells in the SON, LH, or MnPO.



View larger version (117K):
[in this window]
[in a new window]
 
Fig. 1. NADPH-diaphorase-labeled neurons in the paraventricular nucleus (PVN) of the four groups of rats: sham-sedentary, heart failure (HF)-sedentary, sham-exercise trained (Ext), and HF-Ext.

 


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 2. Number of nitric oxide synthase (NOS)-positive cells in the PVN, supraoptic nucleus (SON), lateral hypothalmus (LH), and median preoptic area (MnPO) in sham-sedentary rats, HF-sedentary rats, sham-Ext, rats and HF-Ext rats. Values are means ± SE. *P < 0.05, significantly different from the respective sham group; #P < 0.05, significantly different from the respective sedentary group.

 
Experimental Series 2: Semiquantitative RT-PCR Measurement and Western Blot Analysis for nNOS Protein

The mRNA levels of nNOS were 0.93, 0.58, 0.99, and 1.02 (ratio of intensity) in sham-sedentary, HF-sedentary, sham-ExT, and HF-ExT rats, respectively. There was a significantly lower level of nNOS mRNA in HF-sedentary rats (P < 0.05). ExT enhanced nNOS mRNA significantly in the HF-ExT rats (Fig. 3). Western blot analysis showed 155-kDa bands in the PVN of sham-sedentary and HF-sedentary rats. HF-sedentary rats had significantly lower protein levels of nNOS compared with the other three groups (P < 0.05). Protein expression of nNOS was significantly improved in the HF-ExT rats compared with the HF-sedentary group (Fig. 4).



View larger version (44K):
[in this window]
[in a new window]
 
Fig. 3. Expression of neuronal NOS (nNOS) mRNA in the sham and HF groups. A: representative RT-PCR of nNOS mRNA in the four groups of rats. B: composite data of densitometric analyses of the PCR bands in the four groups of rats. *P < 0.05, significantly different from the respective sham group; #P < 0.05, significantly different from the respective sedentary group.

 


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 4. Expression of nNOS protein in sham and HF groups. A: representative Western blot of nNOS protein in the four groups of rats. B: composite data of nNOS protein expression in the four groups of rats. *P < 0.05, significantly different from the respective sham group; #P < 0.05, significantly different from the respective sedentary group.

 
Experimental Series 3: Microinjection of L-NMMA and SNP into the PVN

Experimental protocol 1. An example of the peak responses in RSNA, BP, and HR to L-NMMA in the four groups is illustrated in Fig. 5. The administration of L-NMMA (50, 100, and 200 pmol) into the PVN elicited a dose-dependent increase in RSNA, BP, and HR in the sham and HF groups (Fig. 6). The HF-sedentary group showed an increase in RSNA that was significantly blunted with all three doses compared with sham rats (P < 0.05). It should be noted that, although HF rats tended to have an increased basal RSNA, the absolute increases in RSNA to L-NMMA were still significantly less in rats with HF. Therefore, the smaller percent changes in RSNA in response to L-NMMA are not due the possible difference in baseline values between groups. ExT significantly normalized the attenuated RSNA responses in rats with HF (33% compared with 20% at the highest dose). There was no significant difference between sham-sedentary rats and HF-ExT rats. A similar trend was observed in BP and HR responses to L-NMMA.



View larger version (35K):
[in this window]
[in a new window]
 
Fig. 5. Segment of an original recording from individual rats demonstrating the baseline parameters and peak changes in renal sympathetic nerve activity (RSNA), blood pressure (BP), and heart rate [HR; in beats/min (bpm)] by administration of NG-monomethyl-L-arginine (L-NMMA) into the PVN in the four groups of rats: sham-sedentary, HF-sedentary, sham-Ext, and HF-Ext. Shown are the baseline parameters with 0 and 200 pmol L-NMMA into the PVN.

 


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 6. Mean changes in RSNA, BP, and HR with the microinjection of L-NMMA into the PVN in sham-sedentary, HF-sedentary, sham-Ext, and HF-Ext groups. Values are means ± SE. *P < 0.05, significantly different from the respective sham group; #P < 0.05, significantly different from the respective sedentary group.

 
Experimental protocol 2. Administration of SNP (5, 10, and 20 nmol) into the PVN produced a dose-dependent decrease in RSNA, BP, and HR in the sham and HF rats (Fig. 7). The HF-sedentary group showed a decrease in RSNA that was significantly blunted with all three doses compared with the other rats (P < 0.05). ExT significantly improved the blunted decrease in RSNA in HF rats (36% compared with 17% at the highest dose). A similar trend was observed in BP and HR responses to SNP.



View larger version (21K):
[in this window]
[in a new window]
 
Fig. 7. Mean changes in RSNA, BP, and HR with the microinjection of sodium nitroprusside into the PVN in sham-sedentary, HF-sedentary, sham-Ext, and HF-Ext rats. Values are means ± SE. *P < 0.05, significantly different from the respective sham group; #P < 0.05, significantly different from the respective sedentary group.

 

    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The results of the present study indicate that there are a decreased number of NOS-positive cells in the PVN of rats with HF. The decreased number of NOS-positive cells in the PVN of rats with HF may contribute to the increased sympathoexcitation in chronic HF. Daily ExT restored the number of nNOS-positive neurons in the PVN of rats with HF. Consistent with these results, nNOS mRNA expression and protein levels in the PVN were also normalized after ExT in rats with HF. Furthermore, blockade of endogenous NO production within the PVN with L-NMMA produced a blunted increase in RSNA, BP, and HR in rats with HF compared with sham-operated rats. Again, ExT normalized the attenuated RSNA responses in rats with HF. Conversely, SNP, microinjected into the PVN, produced a dose-dependent decrease in RSNA in sham and HF rats. ExT significantly improved the blunted decrease in RSNA in HF rats. These data suggest that the sympathoinhibition associated with daily ExT in rats with HF (34) may be due, in part, to the improvement of nNOS levels and NO-mediated mechanisms within the PVN of rats with HF.

The HF condition was documented by the increased cardiac filling pressure, reduced left ventricular contractility, and the size of the myocardial infarct. These rats also demonstrated cardiac hypertrophy and an increased lung wet weight, indicative of pulmonary edema. ExT tended to improve the cardiac hypertrophy, but there was no significant difference between the sedentary and ExT HF rats. Similarly, the contractile function tended to improve in ExT HF rats but was not significantly different between sedentary and ExT HF rats as well as between HF-ExT rats and sham-sedentary rats. However, there was a significant improvement in lung wet weight in ExT HF rats, an index of water accumulation in the pulmonary circulation. Consistent with these observations, there was also a significant difference in the body weight in the sedentary and ExT HF rats, indicative of improvement in peripheral edema and ascites. This would suggest that ExT improved the peripheral circulation and the chronic congestive phase of HF but not the cardiac dysfunction per se.

It is recognized that basal hemodynamic parameters can be affected by acute surgery and anesthesia. We tried to minimize the effects of acute surgery by doing the acute experiments at least an hour after the surgery, when we had stabilized BP and HR. In terms of anesthesia, because these experiments required extensive manipulations, we had to do the experiments in anesthetized rats. In our experience, the level of anesthesia is maintained with urethane-chloralose with a slight depression in BP, but the cardiovascular reflexes remain intact (17). The lower BP may cause a consequent increase in basal RSNA, but because we were able to increase RSNA we believe that this does not confound the data. We are assuming that the effects of surgery and anesthesia are similar between sham and HF groups, because ExT was able to reverse these effects in HF rats but not sham rats (again under these manipulations).

It has been well established that increased sympathetic nerve activity is a characteristic symptom of chronic HF. This sympathoexcitatory state increases the progression and risk of mortality during HF. In patients with HF, elevated sympathetic activity and altered baroreflexes have been reported (39). Norepinephrine release from the failing heart at rest in untreated patients is increased as much as 50-fold (16). Similarly, with the use of an animal model of HF produced by coronary artery ligation, some studies have revealed that RSNA is elevated in both conscious and anesthetized rats with HF (8). It was also found that the volume reflex (7) and the baroreflex (24) were blunted in rats with HF. Recently, several studies have suggested that altered central mechanism(s) may be responsible for the elevated neurohumoral drive in HF (44). In addition to the classical negative feedback of arterial and cardiopulmonary baroreflexes, there are positive feedback, sympathoexcitatory reflexes and humoral regulatory mechanisms that modulate sympathetic outflow centrally.

The PVN is a major site of integration of autonomic and endocrine cardiovascular responses. The parvocellular neurons of the PVN (pPVN) are involved in the mediation of the neural component of cardiovascular reflexes by influencing RSNA (19). Specifically, these studies demonstrated that the PVN is involved in the baroreflex regulation of lumbar sympathetic nerve activity (45). Stimulation of the PVN has been shown to elicit an increased discharge from several sympathetic nerves, including renal (25), adrenal (26), and splanchnic nerves (25). The observations suggest that the PVN plays an essential role in the mediation of RSNA under resting and reflex conditions. Studies from our laboratory have shown increased neuronal activity in the PVN during HF (47), suggesting the involvement of the PVN in the altered sympathetic activity in HF. In contrast, adjacent areas within the hypothalamus such as the SON, LH, and MnPO did not show a significant change in number of NOS-positive cells in rats with HF (59). This further suggested that the change in NOS within the PVN was unique within the hypothalamic areas examined in rats with HF. Whether similar changes in NOS activity within brain stem areas involved in regulating sympathetic outflow, such as the nucleus tractus solitarii, rostral ventrolateral medulla, etc., are altered in HF remains to be elucidated. It is conceivable that such changes within the brain stem may also contribute to the altered sympathetic outflow noted in the HF condition.

Increasing evidence indicates that NO acts as a neuromodulator to affect synaptic function in the central nervous system (2). In the hypothalamus, NOS-positive neurons are found primarily in the PVN and SON (2). NO through a GABA mechanism within the PVN has been shown to decrease RSNA and HR in rats (58). Work from our laboratory (57) and others (20) have shown that administration of the NO donor SNP into the PVN produces a decrease in RSNA and depressor responses in rats. Conversely, it has been observed that administration of the NOS blockers L-NMMA or N-nitro-L-arginine methyl ester into the PVN increases RSNA in rats (57). These responses are significantly blunted, and the sympathoinhibitory effects of NO are less effective in rats with HF (56). These results suggest that the lack of endogenous as well as exogenous NO within the PVN is less effective in decreasing sympathetic nerve activity in rats with HF. The results of the present study are consistent with these previous observations and specifically identify a decreased message for nNOS and protein levels of nNOS in the PVN of rats with HF. Adjacent areas within the hypothalamus such as the LH and SON did not demonstrate similar changes in rats with HF.

Daily exercise is associated with a reduction in arterial pressure (29) and sympathetic nerve activity (4). ExT in rabbits with HF has also been shown to decrease RSNA (34). ExT induced an increase in the density of nNOS-positive neurons, nNOS message, and nNOS protein in rats with HF and may lead to an increase in synthesis of NO in the PVN, which subsequently causes an increased inhibitory effect on RSNA. This suggestion is consistent with improved RSNA responses to microinjection of L-NMMA and SNP into the PVN concomitant with improved nNOS in the PVN of rats with HF.

It has been shown that long-term regular exercise of patients with HF increases the quality of life as well as survival (5). The quality of life was assessed by a questionnaire (Minnesota Living With Heart Failure Questionnaire) consisting of 21 items focused on the patients perceptions concerning the effects of congestive heart failure on their physical, psychological, and socioeconomic lives. This questionnaire is shown to be responsive to changes in quality of life in patients with HF (5). The mechanisms by which ExT improves survival and enhances the quality of life in HF are not completely understood. Experimental evidence indicates that ExT reduces renal sympathetic nerve activity and improves arterial baroreflex in animals with HF (34). It has been found that ExT lowers BP in hypertensive animals, most likely through a NO-dependent mechanism (23). ExT has been shown to upregulate eNOS and endothelium-dependent responses in the coronary circulation of dogs with HF (52). In our present study, the results suggest that ExT enhanced the function and gene expression of endogenous nNOS to regulate sympathetic outflow during HF in the PVN. The time after the last exercise session to conduct the experiments was 20–24 h. A single session of exercise may have effects on hemodynamic lasting 24 h, but we believe that the functional and molecular biological changes that we observe in our experiments are most likely due to long-term ExT rather than an acute effect.

The mechanisms responsible for the ExT-induced increase in nNOS within the PVN remain unknown. However, it is well known that the PVN receives information from various cardiopulmonary receptors including myocardial vagal afferents (37, 38). Some studies suggest that ExT increases various hemodynamic parameters within the heart (HR, cardiac contractility, preload, and afterload) that dictate cardiac vagal activity (9, 10). Some data support the view that enhancement of baroreflex control of HR after ExT is due to an augmentation of vagal tone (35). Accordingly, the activation of cardiac vagal activity during ExT may mediate an increase of nNOS within the PVN resulting in overall sympathoinhibition. This is consistent with the enhanced inhibitory influence of cardiac vagal afferents on directly measured sympathetic activity and regional vascular resistance after ExT (11). The specific role for cardiac vagal afferents remains to be examined.

Angiotensin II has also been implicated as a contributor in the sympathoexcitation observed in HF (33). The levels of angiotensin II are increased in HF, and angiotensin-converting enzyme inhibitors are effective in reducing sympathoinhibition during HF (18, 28). Modulation of NO synthesis and the interaction of NO with angiotensin II in the central nervous system may be an important mechanism for the regulation of sympathetic nerve activity during exercise in HF. Several studies suggest that NO and angiotensin II interact in such a way with regard to sympathetic outflow (33, 36). Angiotensin II acts as a sympathoexcitatory substance that potentiates the effects of NO blockade in normal animals. Blockade of angiotensin II receptors in combination with a NO donor reduces sympathetic nerve activity in animals with HF (36). It has also been shown that ExT of rabbits with HF resulted in a decrease in plasma angiotensin II and resting RSNA despite little improvement in several parameters of cardiac function (34, 40). It is conceivable that one mechanism by which ExT improves the endogenous NO mechanism is related to angiotensin II. This possibility remains to be examined more thoroughly.

There is a body of literature that indicates that voluntary exercise and forced exercise may induce different behavioral and hypothalamic-pituitary-adrenocortical (HPA) responses to stress (13, 14). It has been shown that treadmill ExT has an effect on the metabolism of norepinephrine and the secretion of adrenocorticotropic hormone (ACTH) after foot-shock stress (13). Treadmill ExT has a hyperadrenergic effect in brain areas that modulate hypothalamic regulation of ACTH release during stress (14). Therefore, differential activation of the HPA in response to exercise between the two groups might have different effects on the hypothalamus (including the PVN) during stress. Measures of HPA activity and plasma catecholamines would help to address the question of whether the animals were responding comparably to the exercise challenge (13). However, we believe that this was not the major factor dictating the changes we are reporting here. In this study, we included rats that ran as well (as willingly) in both groups. Those that required more prompting (higher level of potential stress) were not used in this study. There was no difference in the prompting to run between the sham and HF groups, suggesting a similar level of unintended "stress." It should be recognized that this is a mild to moderate level of exercise, which is relatively easy, and the rats were not resistant to exercising, even the HF rats. However, it is recognized that a similar level of stress (even if it was small) may produce different levels of a stress response in HF rats than in sham rats, and this may potentially be involved in these changes. Finally, we did the terminal experiments 1 day after the last bout of running. This would suggest any of the effects of potential stress were perhaps not responsible for the differences observed. These reasons would suggest that stress per se is not likely responsible for the changes observed in the HF-ExT rats.

In conclusion, our data suggest that a reduction of nNOS/NO within the PVN contributes to sympathoexcitation in HF. Furthermore, ExT improves the altered NO mechanisms within the PVN involved in dictating RSNA in rats with HF. The increased NOS may increase the level of NO and contribute to the ExT-induced sympathoinhibition. Although patients with HF have limited exercise capacity, which is, in part, due to a reduced cardiac output, ExT may be an important therapeutic tool for modulating central NO mechanisms dictating sympathetic drive in patients with HF.


    GRANTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This study was supported by National Heart, Lung, and Blood Institute Grant PO1-HL-6222.


    ACKNOWLEDGMENTS
 
The technical assistance of Corrie Karimjee, Xuefei Liu, and Phylis Anding is greatly appreciated.


    FOOTNOTES
 

Address for reprint requests and other correspondence: K. P. Patel, Dept. of Cellular and Integrative Physiology, Univ. of Nebraska Medical Center, 985850 Nebraska Medical Center, Omaha, NE 68198-5850 (E-mail: kpatel{at}unmc.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Belardinelli R, Georgiou D, Cianci G, and Purcaro A. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation 99: 1173–1182, 1999.[Abstract/Free Full Text]
  2. Bredt DS, Hwang PM, and Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347: 768–770, 1990.[CrossRef][Medline]
  3. Chandler MP and DiCarlo SE. Acute exercise and gender alter cardiac autonomic tonus differently in hypertensive and normotensive rats. Am J Physiol Regul Integr Comp Physiol 274: R510–R516, 1998.[Abstract/Free Full Text]
  4. Chen Y, Chandler MP, and DiCarlo SE. Daily exercise and gender influence postexercise cardiac automonic responses in hypertensive rats. Am J Physiol Heart Circ Physiol 272: H1412–H1418, 1997.[Abstract/Free Full Text]
  5. Coats AJ. Exercise training for heart failure-coming of age. Circulation 99: 1138–1140, 1999.[Free Full Text]
  6. Coats AJS, Adamopoulos S, Radaelli A, McCance A, Meyer TE, Bernardi L, Solda PL, Davey P, Ormerod O, Forfar C, Conway J, and Sleight P. Controlled trial of physical training in chronic heart failure: exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 85: 2119–2131, 1992.[Abstract/Free Full Text]
  7. DiBona G, Herman PJ, and Sawin LL. Neural control of renal function in edema-forming states. Am J Physiol Regul Integr Comp Physiol 254: R1017–R1024, 1988.[Abstract/Free Full Text]
  8. DiBona GF, Jones SY, and Brooks VL. ANG II receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure. Am J Physiol Regul Integr Comp Physiol 269: R1189–R1196, 1995.[Abstract/Free Full Text]
  9. DiCarlo SE and Bishop VS. Exercise training enhances cardiac afferent inhibition of baroreflex function. Am J Physiol Heart Circ Physiol 258: H212–H220, 1990.[Abstract/Free Full Text]
  10. DiCarlo SE and Bishop VS. Reginal vascular resistance during exercise: role of cardiac afferents and exercise training. Am J Physiol Heart Circ Physiol 258: H842–H847, 1990.[Abstract/Free Full Text]
  11. DiCarlo SE, Stahl LK, and Bishop VS. Daily exercise attenuates the sympathetic nerve response to exercise by enhancing cardiac afferents. Am J Physiol Heart Circ Physiol 273: H1606–H1610, 1997.[Abstract/Free Full Text]
  12. DiCarlo SE, Zheng H, Collins HL, Rodenbaugh DW, and Patel KP. Daily exercise normalizes the number of diaphorase (NOS) positive neurons in the hypothalamus of hypertensive rats. Brain Res 955: 153–160, 2002.[CrossRef][Web of Science][Medline]
  13. Dishman RK. Brain monoamines, exercise, and behavioral stress: animal models. Med Sci Sports Exerc 29: 63–74, 1997.
  14. Dishman RK, Renner KJ, Whiter-Eelkley JE, Burke KA, and Bunnell BN. Treadmill exercise training augments brain norepinephrine response to familiar and novel stress. Brain Res Bull 52: 337–342, 2000.[CrossRef][Web of Science][Medline]
  15. Drexler H and Lu W. Endothelial dysfunction of hindquarter resistance vessels in experimental heart failure. Am J Physiol Heart Circ Physiol 262: H1640–H1645, 1992.[Abstract/Free Full Text]
  16. Esler M and Kaye D. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol 35, Suppl 4: S1–S7, 2000.[CrossRef]
  17. Faber JE. Effects of althesin and urethan-chloralose on neurohumoral cardiovascular regulation. Am J Physiol Regul Integr Comp Physiol 256: R757–R765, 1989.[Abstract/Free Full Text]
  18. Francis GS. The relationship of the sympathetic nervous system and the renin angiotensin system in congestive heart failure. Am Heart J 118: 642–648, 1989.[CrossRef][Web of Science][Medline]
  19. Haselton JR, Goering J, and Patel KP. Parvocellular neurons of the paraventricular nucleus are involved in the reduction in renal nerve discharge during isotonic volume expansion. J Auton Nerv Syst 50: 1–11, 1994.[CrossRef][Web of Science][Medline]
  20. Horn T, Smith PM, McLaughlin BE, Bauce L, Marks GS, Pittman QJ, and Ferguson AV. Nitric oxide actions in paraventricular nucleus: cardiovascular and neurochemical implications. Am J Physiol Regul Integr Comp Physiol 266: R306–R313, 1994.[Abstract/Free Full Text]
  21. Hornig B, Maier V, and Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation 93: 210–214, 1996.[Abstract/Free Full Text]
  22. Hostetter TH, Pfeffer JM, Pfeffer MA, Dworkin LD, Braunwald E, and Brenner BM. Cardiorenal hemodynamics and sodium excretion in rats with myocardial infarction. Am J Physiol Heart Circ Physiol 245: H98–H103, 1983.[Abstract/Free Full Text]
  23. Jonsdottir IH, Jungersten L, Johansson C, Wennmalm A, Thorén P, and Hoffmann P. Increase in nitric oxide formation after chronic voluntary exercise in spontaneously hypertensive rats. Acta Physiol Scand 162: 149–153, 1998.[CrossRef][Web of Science][Medline]
  24. Jung R, Dibner-Dunlap ME, Gilles MA, and Thames MD. Cardiorespiratory reflex control in rats with left ventricular dysfunction. Am J Physiol Heart Circ Physiol 268: H218–H225, 1995.[Abstract/Free Full Text]
  25. Kannan H, Hayashida Y, and Yamashita H. Increase in sympathetic outflow by paraventricular nucleus stimulation in awake rats. Am J Physiol Regul Integr Comp Physiol 256: R1325–R1330, 1989.[Abstract/Free Full Text]
  26. Katafuchi TY, Oomura Y, and Kurosawa M. Effects of chemical stimulation of paraventricular nucleus on adrenal and renal nerve activity in rats. Neurosci Lett 86: 195–200, 1988.[CrossRef][Web of Science][Medline]
  27. Kaye DM, Lefkovits J, Cox H, Lambert G, Jennings G, Turner A, and Esler MD. Regional epinephrine kinetics in human heart failure: evidence for extra-adrenal, nonneural release. Am J Physiol Heart Circ Physiol 269: H182–H188, 1995.[Abstract/Free Full Text]
  28. Kinugawa T, Ogino K, kitamura H, Saitoh M, Omodani H, Osaki S, Hisatome I, and Miyakoda H. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure. Am J Med Sci 312: 110–117, 1996.[CrossRef][Web of Science][Medline]
  29. Kramer JM, Beatty JA, Little HR, Plowey ED, and Waldrop TG. Chronic exercise alters caudal hypothalamic regulation of the cardiovascular system in hypertensive rats. Am J Physiol Regul Integr Comp Physiol 280: R389–R397, 2001.[Abstract/Free Full Text]
  30. Laughlin MH, Schrage WG, McAllister RM, Garverick HA, and Jones AW. Interacton of gender and exercise training: vasomotor reactivity of porcine skeletal muscle arteries. J Appl Physiol 90: 216–227, 2001.[Abstract/Free Full Text]
  31. Leenen FHH, Huang BS, Yu HL, and Yuan BX. Brain "ouabain" mediates sympathetic hyperactivity in congestive heart failure. Circ Res 77: 993–1000, 1995.[Abstract/Free Full Text]
  32. Leimbach WN, Gunner wallin B, Victor RG, Aylward PE, Sundlof G, and Mark AL. Direct evidence from intraneural recordings for increased central symapthetic outflow in patients with heart failure. Circulation 73: 913–919, 1986.[Abstract/Free Full Text]
  33. Li YF and Patel KP. Effect of angiotensin (AII) within the paraventricular nucleus on renal sympathetic nerve discharge is moderated by an NO mechanism. FASEB J 15: A800, 2001.
  34. Liu JL, Irvine S, Reid IA, Patel KP, and Zucker IH. Chronic exercise reduces sympathetic nerve activity in rabbits with pacing-induced heart failure–a role for angiotensin II. Circulation 102: 1854–1862, 2000.[Abstract/Free Full Text]
  35. Liu JL, Kulakofsky J, and Zucker IH. Exercise training enhances baroreflex control of heart rate by a vagal mechanism in rabbits with heart failure. J Appl Physiol 92: 2403–2408, 2002.[Abstract/Free Full Text]
  36. Liu JL, Murakami H, and Zucker IH. Angiotensin II nitric oxide interaction on sympathetic outflow in conscious rabbits. Circ Res 82: 496–502, 1998.[Abstract/Free Full Text]
  37. Lovick TA and Coote JH. Effects of volume loading on paraventriculo-spinal neurones in the rat. J Auton Nerv Syst 25: 135–140, 1988.[CrossRef][Web of Science][Medline]
  38. Lovick TA and Coote JH. Electrophysiological properties of paraventriculo-spinal neurones in the rat. Brain Res 454: 123–130, 1988.[CrossRef][Web of Science][Medline]
  39. Mancia G. Sympathetic activation in congestive heart failure. Europ Heart J 11, Suppl A: 3–11, 1990.
  40. Murakami H, Liu JL, and Zucker IH. Angiotensin II enhances baroreflex control of sympathetic outflow in heart failure. Hypertension 29: 564–569, 1997.[Abstract/Free Full Text]
  41. Musch TI and Terrell JA. Skeletal muscle blood flow abnormalities in rats with a chronic myocardial infarction: rest and exercise. Am J Physiol Heart Circ Physiol 262: H411–H419, 1992.[Abstract/Free Full Text]
  42. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 77: 721–730, 1988.[Free Full Text]
  43. Palkovits M and Brownstein M. Brain microdissection techniques. In: Brain Microdissection Techniques, edited by Cuello AE. Chichester: Wiley, 1983.
  44. Patel KP. Neural regulation in experimental heart failure. Baillieres Clin Neurol 6: 283–296, 1997.[Medline]
  45. Patel KP and Schmid PG. Role of the paraventricular nucleus (PVH) in baroreflex-mediated changes in lumbar sympathetic nerve activity and heart rate. J Auton Nerv Syst 22: 211–219, 1988.[CrossRef][Web of Science][Medline]
  46. Patel KP, Zhang PL, and Carmines PK. Neural influences on renal responses to acute volume expansion in rats with heart failure. Am J Physiol Heart Circ Physiol 271: H1441–H1448, 1996.[Abstract/Free Full Text]
  47. Patel KP, Zhang PL, and Krukoff TL. Alterations in brain hexokinase activity associated with heart failure in rats. Am J Physiol Regul Integr Comp Physiol 265: R923–R928, 1993.[Abstract/Free Full Text]
  48. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates. Orlando, FL: Academic, 1986.
  49. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, and Braunwald E. Myocardial infarct size and ventricular function in rats. Circ Res 44: 503–512, 1979.[Abstract/Free Full Text]
  50. Rowell LB. Human Circulation Regulation during Physical Stress. New York: Oxford University Press, 1986.
  51. Saper CB, Loewy AD, Swanson LW, and Cowan WM. Direct hypothalamo-autonomic connections. Brain Res 117: 305–312, 1976.[CrossRef][Web of Science][Medline]
  52. Smith CJ, Sun D, Hoegler C, Roth BS, Zhang X, Zhao G, Xu XB, Kobari Y, Pritchard K Jr, Sessa WC, and Hintze TH. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res 78: 58–64, 1996.[Abstract/Free Full Text]
  53. Srere PA. Citrate synthase. Methods Enzymol 13: 3–11, 1969.
  54. Swanson LW and Sawchenko PE. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 6: 269–324, 1983.[CrossRef][Web of Science][Medline]
  55. Swanson LW and Sawchenko PE. Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology 31: 410–417, 1980.[Web of Science][Medline]
  56. Zhang K, Li YF, and Patel KP. Blunted nitric oxide-mediated inhibition of renal nerve discharge within PVN of rats with heart failure. Am J Physiol Heart Circ Physiol 281: H995–H1004, 2001.[Abstract/Free Full Text]
  57. Zhang K, Mayhan WG, and Patel KP. Nitric oxide within the paraventricular nucleus mediates changes in renal sympathetic nerve activity. Am J Physiol Regul Integr Comp Physiol 273: R864–R872, 1997.[Abstract/Free Full Text]
  58. Zhang K and Patel KP. Effect of nitric oxide within the paraventricular nucleus on renal sympathetic nerve discharge: role of GABA. Am J Physiol Regul Integr Comp Physiol 275: R728–R734, 1998.[Abstract/Free Full Text]
  59. Zhang K, Zucker IH, and Patel KP. Altered number of diaphorase (NOS) positive neurons in the hypothalamus of rats with heart failure. Brain Res 786: 219–225, 1998.[CrossRef][Web of Science][Medline]



This article has been cited by other articles:


Home page
Exp PhysiolHome page
L. C. Michelini and J. E. Stern
Exercise-induced neuronal plasticity in central autonomic networks: role in cardiovascular control
Exp Physiol, September 1, 2009; 94(9): 947 - 960.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y.-M. Kang, R.-L. He, L.-M. Yang, D.-N. Qin, A. Guggilam, C. Elks, N. Yan, Z. Guo, and J. Francis
Brain tumour necrosis factor-{alpha} modulates neurotransmitters in hypothalamic paraventricular nucleus in heart failure
Cardiovasc Res, September 1, 2009; 83(4): 737 - 746.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y.-M. Kang, Y. Ma, C. Elks, J.-P. Zheng, Z.-M. Yang, and J. Francis
Cross-talk between cytokines and renin-angiotensin in hypothalamic paraventricular nucleus in heart failure: role of nuclear factor-{kappa}B
Cardiovasc Res, September 1, 2008; 79(4): 671 - 678.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y.-M. Kang, Z.-H. Zhang, B. Xue, R. M. Weiss, and R. B. Felder
Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H227 - H236.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. C. Kleiber, H. Zheng, H. D. Schultz, J. D. Peuler, and K. P. Patel
Exercise training normalizes enhanced glutamate-mediated sympathetic activation from the PVN in heart failure
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1863 - R1872.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y.-X. Pan, L. Gao, W.-Z. Wang, H. Zheng, D. Liu, K. P. Patel, I. H. Zucker, and W. Wang
Exercise Training Prevents Arterial Baroreflex Dysfunction in Rats Treated With Central Angiotensin II
Hypertension, March 1, 2007; 49(3): 519 - 527.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. J. Mueller
Exercise training attenuates increases in lumbar sympathetic nerve activity produced by stimulation of the rostral ventrolateral medulla
J Appl Physiol, February 1, 2007; 102(2): 803 - 813.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. K. Reddy, H. D. Schultz, H. Zheng, and K. P. Patel
Altered nitric oxide mechanism within the paraventricular nucleus contributes to the augmented carotid body chemoreflex in heart failure
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H149 - H157.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Zheng, Y.-F. Li, I. H. Zucker, and K. P. Patel
Exercise training improves renal excretory responses to acute volume expansion in rats with heart failure
Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1148 - F1156.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Koba, Z. Gao, J. Xing, L. I. Sinoway, and J. Li
Sympathetic responses to exercise in myocardial infarction rats: a role of central command
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2735 - H2742.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. C. Frisbee, J. B. Samora, J. Peterson, and R. Bryner
Exercise training blunts microvascular rarefaction in the metabolic syndrome
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2483 - H2492.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y.-M. Kang, Z.-H. Zhang, R. F. Johnson, Y. Yu, T. Beltz, A. K. Johnson, R. M. Weiss, and R. B. Felder
Novel Effect of Mineralocorticoid Receptor Antagonism to Reduce Proinflammatory Cytokines and Hypothalamic Activation in Rats With Ischemia-Induced Heart Failure
Circ. Res., September 29, 2006; 99(7): 758 - 766.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
K. Jackson, H. M. V. Silva, W. Zhang, L. C. Michelini, and J. E. Stern
Exercise Training Differentially Affects Intrinsic Excitability of Autonomic and Neuroendocrine Neurons in the Hypothalamic Paraventricular Nucleus
J Neurophysiol, November 1, 2005; 94(5): 3211 - 3220.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/5/H2332    most recent
00473.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (26)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zheng, H.
Right arrow Articles by Patel, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zheng, H.
Right arrow Articles by Patel, K. P.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.